2000
Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in the medical technology industry, is today joining a number of the nation''s leading health care companies and...
Indianapolis, IN and Santa Clara, CA - Patients at risk of experiencing life-threatening abrupt closures in small blood vessels may soon benefit from new technology developed to prevent blocked...
Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), today announced all-time record sales of $668.4 million for the second quarter of 2000, an increase of 9 percent over the second quarter...
Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a worldwide leader in implantable medical device systems, today announced that the CONTAK CD heart failure device...
Indianapolis, IN and Santa Clara, CA - Guidant Corporation (NYSE and PCX: GDT) a world leader in the treatment of coronary artery disease, today announced FDA marketing clearance for two new...
Briefing Serves as a Call to Action to Address Significant Health Concern Indianapolis, IN - In an effort to provide increased visibility to a growing public health crisis-cardiovascular disease...
Data from INHIBIT Trial Shows In-Stent Restenosis Reduction With Radiotherapy Indianapolis, Ind. and Santa Clara, Calif. - Results from the INHIBIT (INtimal Hyperplasia Inhibition with Beta...
Landmark Study Examines Minimally Invasive Alternative for Treating Carotid Artery Disease Indianapolis, Ind., Santa Clara, Calif. and Newark, N.J. - Guidant Corporation (NYSE and PCX: GDT) and...
Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of coronary artery disease, announced today that is has filed with the U.S....
Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a global leader in the development of medical technology for the treatment of cardiovascular and vascular disease, today announced...